Medicare Enrolled
Dr. Magdalena Kowalski, MD
Family Medicine · Ringgold, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kowalski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kowalski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kowalski
Dr. Magdalena Kowalski is a family medicine specialist in Ringgold, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kowalski performed 8,464 Medicare services across 3,223 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kowalski received a total of $11,755 from 37 pharmaceutical and/or device companies across 522 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kowalski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in GA
$11,755 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,464
Medicare services
Top 2% in GA for family medicine
3,223
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~423 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
2,284 | $4 | $7 |
| Superficial or low voltage radiation treatment A radiation therapy procedure that delivers radiation to the surface of the body or uses low voltage energy. This treatment targets areas close to the skin. |
1,497 | $29 | $52 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
884 | $37 | $54 |
| Radiation treatment planning, 1 area This procedure involves gathering the necessary data to design the most effective radiation therapy plan for a single treatment area. |
864 | $189 | $329 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
722 | $38 | $82 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
561 | $60 | $91 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
374 | $1 | $2 |
| Calculation of radiation therapy dose | 340 | $47 | $83 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
264 | $65 | $122 |
| Radiation treatment planning, complex This procedure involves obtaining the necessary data to develop an optimal radiation treatment plan for three or more treatment areas, or any number of areas requiring special treatment. |
190 | $324 | $621 |
| Destruction of 15 or more precancerous skin growths This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer. |
93 | $112 | $186 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
77 | $35 | $66 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
62 | $71 | $135 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
60 | $85 | $135 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
58 | $44 | $93 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
41 | $10 | $31 |
| Chemotherapy administration, 1-7 injections This procedure involves the administration of chemotherapy medication through one to seven separate injections. |
40 | $53 | $103 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
22 | $72 | $135 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
17 | $30 | $69 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $107 | $207 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,755
Total received (2018-2024)
Avg $1,679/year across 7 years
Top 4% in GA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
522
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,743 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,957
2023
$2,815
2022
$2,465
2021
$1,540
2020
$538
2019
$992
2018
$449
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$666
ABBVIE INC.
$293
GENZYME CORPORATION
$254
Lilly USA, LLC
$245
Novartis Pharmaceuticals Corporation
$228
Dermavant Sciences, Inc.
$204
E.R. Squibb & Sons, L.L.C.
$186
UCB, Inc.
$153
Janssen Biotech, Inc.
$134
Incyte Corporation
$133
Novo Nordisk Inc
$119
SUN PHARMACEUTICAL INDUSTRIES INC.
$81
Amgen Inc.
$75
PFIZER INC.
$62
Galderma Laboratories, L.P.
$38
Ortho Dermatologics, a division of Bausch Health US, LLC
$33
Arcutis Biotherapeutics, Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Almirall LLC
$17
Top 3 companies account for 41.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,710
ABBVIE INC.
$1,482
Lilly USA, LLC
$1,399
Regeneron Healthcare Solutions, Inc.
$898
GENZYME CORPORATION
$684
Janssen Biotech, Inc.
$593
Incyte Corporation
$567
Amgen Inc.
$543
PFIZER INC.
$444
Dermavant Sciences, Inc.
$400
E.R. Squibb & Sons, L.L.C.
$355
UCB, Inc.
$326
Sun Pharmaceutical Industries Inc.
$265
Galderma Laboratories, L.P.
$220
Ortho Dermatologics, a division of Bausch Health US, LLC
$216
AbbVie Inc.
$186
SUN PHARMACEUTICAL INDUSTRIES INC.
$160
Aclaris Therapeutics, Inc.
$146
MAYNE PHARMA INC.
$137
Mayne Pharma Inc.
$131
AbbVie, Inc.
$130
Almirall LLC
$122
Novo Nordisk Inc
$119
LEO Pharma Inc.
$95
DERMIRA, INC.
$91
Arcutis Biotherapeutics, Inc.
$80
VYNE Pharmaceuticals Inc.
$52
SANOFI-AVENTIS U.S. LLC
$37
MAYNE PHARMA COMMERCIAL LLC
$27
Merck Sharp & Dohme LLC
$24
PruGen, Inc. Pharmaceuticals
$21
Radius Health, Inc.
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Shire North American Group Inc
$16
BOSTON SCIENTIFIC CORPORATION
$15
DUSA Pharmaceuticals, Inc.
$14
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 39.1% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMZEEQ · ARAZLO · Aimovig · BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 · Bimzelx · CIBINQO · COSENTYX · Cimzia · Cordran · DORYX · DUOBRII · DUPIXENT · EBGLYSS · ELIDEL · ENSTILAR · EPIDUO FORTE · EPSOLAY · ESKATA · EUCRISA · Enbrel · GENERAL PAIN MANAGEMENT · HUMIRA · Humira · ILUMYA · Ilumya · JANUVIA · JUBLIA · LIBTAYO · LITFULO · NATPARA (PARATHYROID HORMONE) · OLUMIANT · OPZELURA · ORACEA · Otezla · PICATO · QBREXZA · REMICADE · RHOFADE · RINVOQ · Repatha · SILIQ · SKYRIZI · SOLIQUA 100/33 · SOOLANTRA · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TOUJEO · TREMFYA · Tymlos · VTAMA · Winlevi · XARELTO · XELJANZ · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for family medicine in GA.
Geographic Context
Family medicine physicians within 10 mi
266
Per 100K population
389.1
County median income
$72,425
Nearest hospital
CHI MEMORIAL HOSPITAL- GEORGIA
6.7 mi
6.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kowalski is a clinical cardiology specialist, with above-average Medicare volume (top 2% in GA), with low-engagement industry engagement in the top 4% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kowalski experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Kowalski performed 2,284 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kowalski receive payments from pharmaceutical companies?
Yes. Dr. Kowalski received a total of $11,755 from 37 companies across 522 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kowalski's costs compare to other family medicine physicians in Ringgold?
Dr. Kowalski's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kowalski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Ringgold
Browse family medicine physicians in Ringgold ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in GA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in GA
Which GA family medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology